DailyIQ
|
DailyIQ
|
Last updatedUpdating…

NBTX·Nanobiotix S.A.

$30.02
+0.32 (+1.08%)
Pre-Market
High
$30.11
Open
$30.11
Market Cap
1.37B
52W High
$57.14
Low
$29.96
P. Close
$30.02
P/E
-
52W Low
$19.03
Fwd P/E
-178.98
DailyIQ Est.
$59.33
Inst. Own.
12.5%
Short Interest
0.43%
Days to Cover
1.2
Technical Score (1D)
67
BULLISH
News Sentiment
35
BEARISH
The technical picture for Nanobiotix S.A. (NBTX) is bullish, scoring 67 out of 100 on the 1D view. Momentum is firm and sentiment, at 35, is diverging from the price action - a combination that historically precedes follow-through moves. Buyers have maintained control above $28.77, and the path of least resistance points toward $31.17. With the bearish MACD posture in place, the setup remains constructive and worth monitoring for continuation. The gap between the 1D chart and the sentiment read is the kind of thing that shows up in hindsight as either the setup that shook out weak hands before running, or the one that should have been faded. Until $31.17 clears with real volume, sizing should reflect that ambiguity rather than the technical score in isolation - $28.77 is the level where that ambiguity gets resolved one way or the other.
LOW TARGET
$30 +1.0%
1 analysts
MEAN TARGET
$55 +82.2%
6 analysts
HIGH TARGET
$70 +134.4%
7 analysts
PRICE RANGE
$30.26 - $70.26
SB / B / H / S / SS
5/6/1/1/1
DAILYIQ EST.
$59.33 (+98.0%)
100/ 100
Strong bullish
Overall: Bullish
✓Analyst target above current price
View full financials →

EPS

EstBeatMiss
No data available
QtrEstActual+/−
Q3'26 - - -

Revenue

EstBeatMiss
No data available
QtrEstActual+/−
Q3'26 - - -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

NBTX Stock Snapshot

BULLISH67/100
$29.97−$0.05 (0.2%)
Market cap
1.37B
Day range
$29.96 – $30.11
News sentiment
35/100 · Bearish
Analyst target
$54.60 (+82.2%)
Consensus
Buy · 14 analysts
52-week range+57.5% off low · -47.5% from high
$19.03$57.14
Price $29.97 DailyIQ Est. $59.33

NBTX is trading with the trend behind it, which is what pushes the technical read bullish. Position sizing matters more than usual in a name this size, where volatility is structural.

Behaviour On Record

What NBTX's own history says about today's numbers

Realized volatility (21d)
109.8% 83rd pct
Below its peak
-45.0%
vs 200-day average
-12.5%
Up days (1y)
50%

Nanobiotix S.A. is currently running 109.8% annualised volatility over the last 21 sessions. Measured against NBTX's own 4 years of daily returns rather than a market-wide average, that is the 83rd percentile — elevated for this stock, against a typical reading of 77.0%.

NBTX is trading -45.0% below its running peak. Across 3 full years on file, its median worst-drawdown-in-a-year was -61.0%, and the deepest was -63.8% in 2021. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits -12.5% from its 200-day moving average. Against every other day in its history, that gap ranks at the 44th percentile — close to the gap it normally carries. Over the past year NBTX closed higher on 50% of sessions, and it is currently 2 sessions into a rising streak.

Overnight risk is measurable too: NBTX has opened more than 2% away from the prior close in 547 of 979 sessions (55.9% of the time), with the largest gaps running +54.1% and -17.3%.

All figures computed from 981 daily closes between 2020-12-14 and 2026-11-04, split-adjusted, recomputed daily. Percentiles are against NBTX's own 6-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of NBTX's sector?

Nanobiotix S.A. sits in the Health Care sector, currently ranked 1st of 12 GICS sectors by relative-strength rotation score (weakening). Within its narrower Biotechnology industry group, NBTX ranks 9th of 15 tracked industries, weakening.

Sector rank
#1 of 12
Sector state
Weakening
Sector rotation score
82
Industry rank
#9 of 15

Options Market

What is the options market pricing for NBTX?

CallsPuts

For Nanobiotix S.A.'s nearest expiry (2026-11-20, 14 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.00).

Put/call ratio (2026-11-20)
0.00
Total open interest
11

Analyst Consensus Estimates

What do analysts expect NBTX to earn?

Analysts expect Nanobiotix S.A. to earn -$0.62 per share in the fiscal year ending Dec 2026 and $0.16 in the fiscal year ending Dec 2027, from 2 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026-$0.62-$0.90 to -$0.332--
Dec 2027$0.16-$0.45 to $0.762--

Analyst Rating Changes

Are analysts turning bullish or bearish on NBTX?

Leerink Partners most recently reiterated its rating on Nanobiotix S.A. to Outperform on Jun 4, 2026 with a price target of $46 (from $37). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Leerink Partners: Outperform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Jun 4, 2026Leerink PartnersMaintainedOutperform$37 → $46
May 1, 2026UBSMaintainedNeutral$4 → $30
Apr 2, 2026GuggenheimMaintainedBuy$26 → $36
Feb 6, 2026GuggenheimMaintainedBuy$8 → $26
Apr 4, 2025GuggenheimMaintainedBuy$12 → $8
Aug 28, 2024GuggenheimInitiatedBuy$12
Dec 8, 2023Leerink PartnersInitiatedOutperform$11
Jan 6, 2021Evercore ISI GroupInitiatedOutperform-

Corporate Stakes

Which companies own a stake in NBTX?

12.31%held by JNJ

Johnson & Johnson reports a stake in Nanobiotix S.A. on SEC Form 13F: 5.6M shares, about 12.31% of the company, worth $175.2M at the end of Q3 2026. At today's price that stake is worth $168.5M, about 0.02% of JNJ's own market value.

Holder
JNJ
Shares held
5.6M
Stake
12.31%
Value
$175.2M
HolderLast quarterShares% of NBTXValue at filingValue nowChange
Johnson & Johnson JNJUnchanged5.6M12.31%$175.2M$168.5M-3.8%

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it. Value now and Change put those same shares, adjusted for any stock split, at today's price against their reported quarter-end value, so they do not reflect buying or selling since.

News & sentiment

What is the news saying about NBTX?

NBTX rose 18.8% over the month to Nov 6. News tone held between 50 and 100 from Oct 20 to Oct 26, then dropped to 32 on Oct 30.

Daily close and news tone, Oct 6 to Nov 6
$20$30Oct 6Oct 7Oct 8Oct 9Oct 12Oct 13Oct 14Oct 15Oct 16Oct 19Oct 20: tone 51Oct 21: tone 100Oct 22Oct 23Oct 26: tone 72Oct 27Oct 28Oct 29Oct 30: tone 32Nov 2: tone 0Nov 3Nov 4Nov 5Nov 6Oct 6News toneNov 6123
  1. Oct 20 +14.5%
  2. Oct 22 +13.0%
  3. Oct 27 +14.2%
Latest stories naming Nanobiotix

Technical analysis

How strong is NBTX's momentum right now?

On the daily chart NBTX ranks at the 67th percentile for momentum against 1,060 stocks and ETFs, a bullish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling NBTX?

8 of the 11 tracked managers added to NBTX in their latest 13F and 2 trimmed. Together they own 0.2% of the company, worth $2.1M. Jane Street and HRT Financial alone hold 0.1%.

8adding2trimming1unchanged
Largest holders by stake, latest 13FBar = share of NBTX
  1. 1Jane Street Group, LLC0.07%
    $1.2M positionNew position last quarter
  2. 2HRT Financial LP0.06%
    $1.0K positionNew position last quarter
  3. 3Optiver Holding B.V.0.03%
    $513.9K positionAdded 1.0% last quarter
  4. 4BNP Paribas Financial Markets<0.01%
    $152.5K positionAdded 13.6% last quarter
  5. 5UBS Group AG<0.01%
    $97.2K positionTrimmed 53.6% last quarter
  6. 6Royal Bank of Canada<0.01%
    $83.0K positionAdded 19.9% last quarter
  7. 7RhumbLine Advisers<0.01%
    $56.6K positionTrimmed 34.2% last quarter
  8. 8Federation des caisses Desjardins du Quebec<0.01%
    $2.1K positionNew position last quarter
  9. 9NISA Investment Advisors, LLC<0.01%
    $872 positionNew position last quarter
  10. 10National Bank of Canada<0.01%
    $482 positionUnchanged last quarter
Full holdings history

Discover more

How has NBTX done against its peers?

Over the six months to Nov 6, NBTX returned −27.1%. Of the 15 related stocks and ETFs, all did better, led by MRNA at +389.9%.

Change since May 6, through Nov 6
−200%0%+200%+400%+600%May 6JunJulAugSepOctNov 6MRNA +389.9%NBTX −27.1%